Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. PRHSX: which is better?

Bottom line

FHLC vs PRHSX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 78% by weight.

FHLC is cheaper at 0.084% vs 0.83% — a difference of $75 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +4.2% for PRHSX (reporting dates differ).

Updated Nov 19, 2026

FHLC vs PRHSX side by side

FHLCPRHSX
TypeETFMutual fund
Fund familyFidelityT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.83%
Annual cost per $10k$8.4$83
10-yr cost on $10k (prospectus)$108$1,025
Max front loadNone—
12b-1 fee0%—
1-yr return+2.6%+17.7%
5-yr return (annualized)+7.2%+4.2%
10-yr return (annualized)+8.8%+9.1%
Best quarter+16.4%+23.5%
Worst quarter−13.1%−15.8%
Net assets (fund)$3.3B$11.9B
Number of holdings337279
Portfolio turnover3%62%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCPRHSXDifference
2024+2.6%+1.8%+0.8%
2023+2.5%+3.1%−0.6%
2022−5.5%−12.2%+6.7%
2021+20.4%+13.3%+7.1%
2020+18.1%+30.1%−12.0%
2019+21.9%+29.1%−7.2%
2018+5.5%+1.2%+4.3%
2017+23.3%+28.0%−4.6%
2016−3.3%−10.4%+7.0%

Source: Fund prospectus bar charts

Holdings overlap

17 of FHLC's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingFHLCPRHSX
Eli Lilly & Co13.35%14.28%
Johnson & Johnson8.93%6.63%
AbbVie Inc6.42%5.10%
UnitedHealth Group Inc5.44%5.99%
Merck & Co Inc4.66%4.01%
Thermo Fisher Scientific Inc3.09%2.52%
Amgen Inc3.00%1.82%
Abbott Laboratories2.66%1.89%
Gilead Sciences Inc2.34%2.82%
Bristol-Myers Squibb Co1.93%2.11%
CVS Health Corp1.92%0.94%
Intuitive Surgical Inc1.82%1.87%
Danaher Corp1.80%1.43%
Vertex Pharmaceuticals Inc1.76%2.28%
Stryker Corp1.62%1.78%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between FHLC and PRHSX?
FHLC (Fidelity MSCI Health Care Index ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 78% by weight. FHLC is cheaper at 0.084% vs 0.83% — a difference of $75 a year per $10,000 invested.
Which is cheaper, FHLC or PRHSX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and PRHSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.